Healthcare utilization and costs for patients initiating Dabigatran or Warfarin

from Health and Quality of Life Outcomes at on June 22, 2017 at 11:57AM

Novel oral anticoagulants (NOAC) such as dabigatran, when compared to warfarin, have been shown to potentially reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) together with l…